股票资讯 | 英国《金融时报》发表文章称:全世界都在看好阿里巴巴

wechat omage

 

美国股市

特朗普周一表示,只要有新的、公平的NAFTA协议签署,加拿大和墨西哥两国可被豁免在全球钢铝关税之外。此后,多位美国高官均表达美国没有寻求贸易战。这进一步缓解了市场对贸易战的担忧。

因此,昨夜标普500指数收涨7.18点,涨幅0.26%,报2728.12点。道指收涨9.36点,涨幅0.04%,报24884.12点。纳指收涨41.30点,涨幅0.56%,报7372.01点。
美国科技股涨跌各异,苹果收跌0.08%,Facebook和微软分别收跌0.34%。谷歌母公司Alphabet收涨0.56%,亚马逊收涨0.92%, 英伟达收涨2.76%,奈飞收涨3.24%。
中概股新浪收涨3.23%,京东收涨0.35%,网易收涨2.01%,百度收涨1.51%,阿里巴巴收涨3.18%,微博收涨3.29%.
转自凤凰网,英国《金融时报》刊登了题为《全世界都在看好阿里巴巴》的文章,并称“买入阿里巴巴是全世界最拥挤的交易区域”。
同时,对于阿里巴巴的热情同样反映在华尔街评级机构们对阿里巴巴的评级上,在53家专业分析机构中,51家持有“买入”或者“强烈买入”的评级,另外两家的评级为“持有”,没有一家分析机构认为应该卖出阿里巴巴股票。
在美国投资者聚集的社区Investorplace上,有文章详细的检视了新的一年中,阿里巴巴的业务前景。一篇题为“阿里巴巴依然是一个让人成功的投资”的文章称“阿里巴巴对于成为全渠道商业公司非常非常严肃”,在2017年以收购银泰开始,又以收购中国最大的零售商结尾(高新零售)。
该篇文章还称,如果云计算和数字零售业务在新的国际市场继续成功,同时阿里的新零售业务持续进展,那么阿里的营收在接下来的五年到十年内可以轻松翻番,或翻三番。此前,美国新闻与世界报道则对于2018年最值得投资的股票进行了推荐:即使已经180美元,阿里巴巴也是最值得购买的股票之一。文章指出,中国经济的巨大体量和光明前景,给了阿里巴巴极好的未来。美国新闻和世界报道认为,中国凭借十三亿人口和每年6%以上的增长,用不了几年就会超过美国。

中国股市

昨日沪指先抑后扬,午后煤炭、钢铁、券商等前期热点板块纷纷回暖,推动沪指震荡走强,涨幅扩大;创业板1800点整数关口得而复失,尾盘勉强收红。
截至收盘,沪指报3289.64点,涨32.71点,涨幅1.00%,成交2244亿元;深成指报11007.95点,涨132.27点,涨幅1.22%,成交2740亿元;创业板报1797.61点,涨1.92点,涨幅0.11%,成交821.5亿元。
行业板块方面,煤炭、钢铁和有色金属等周期性较强的行业板块涨幅居前,板块指数涨幅均超2%,保险、券商和地产等权重股午后表现也不错,医药和医疗两大板块全天维持强势。另外,早盘表现较好的软件服务、电子信息和电子元件等科技板块午后涨幅纷纷回落。
近期沪指多次出现盘中震荡下探走势,但反弹的形态并未破坏,依然保持比较强势状态。短期市场形成了上有阻力、下有支撑的格局,预计短线沪指仍将维持震荡走势。

香港股市

昨日恒生指数低开低走,午后跌幅扩大逾2%,截至收盘,恒生指数跌2.28%,报29886.39点。大市成交1184.7亿港元。沪港通资金流向方面,沪股通净流出12.34亿,港股通(沪)净流出0.87亿;深港通资金流向方面,深股通净流出0.55亿,港股通(深)净流入9.99亿。所有板块午后全部下跌,科技、银行、零售股跌幅居前。
成交金额前五的个股全部下跌,腾讯控股、中国平安跌超2.5%,建设银行跌2.75%,香港交易所跌3.01%,汇丰控股跌1.62%。内银股及通讯股跌势惨重,工商银行跌1.95%,中国银行跌1.43%;中国移动跌3.17%,中国联通大跌5.93%。
另一方面,上交所发布通知,调整沪港通下港股通股票名单。新进入港股通名单的个股中,亦有部分录得上涨,包括阅文集团、中国宏桥、易鑫集团、新城发展控股、合生创展集团。

关键词:股票,香港股市,港股,香港IPO,交易港股,新加坡交易港股,美股,中国A股,股市资讯, alibaba,阿里巴巴股票,阿里,美国上市

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com